PharmaWatch: Novo Nordisk and Sanofi Facing Lawsuit Over Insulin Pricing

TrialSite News has covered some of the apparent insulin pricing issues  in the market. Although a federal judge precluded federal racketeering claims, he did greenlight claims under 25 states’ consumer protection statutes. The plaintiffs allege that the pharmaceutical companies deceptively raised prices making insulin less affordable to patients. TrialSite News will monitor the legal wire for material updates.